Organon partners with Huya to identify and develop Chinese biopharmaceuticals
Collaboration looks for opportunities to expand the Organon biotech research programs and facilitate links with China's biotech industry
11-Jan-2007
HUYA, with offices in San Diego and Shanghai, identifies, licenses and develops Chinese drug candidates for commercialization in Western markets. Under the collaboration agreement, HUYA will support Organon in the sourcing and development of pharmaceutical or biopharmaceutical compounds in three specific therapeutic areas.
No financial details of the transaction were disclosed.
Most read news
Organizations
N.V. Organon
HUYA Bioscience International
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.